I can't speak on the clinical matters, but on the financial ones this looks a nice acquisition.
Interested to ntoe the comments on working capital requirements. I've wondered whether LHC are lax on working capital mgmt, so seeing a public comment on this, albeit in respect of a new acquisition rather than the existing operations, was reassuring, IMHO. GLAH